GitLab's results don't justify the stock's after-hours rise. Expense dollars grew far faster than revenue dollars, 117% net retention is unimpressive at this valuation, and stock-based compensation rose 50% year over year. x.com
Broken Moats
Family-Office Long/Short Research, Variant Perception
GitLab doesn't justify 65x forward earnings or a 17% post-earnings jump. Gross margin is compressing, possibly structurally, the quarter and guide show little operating leverage, it is still EBIT-negative at a $9.2bn market cap, and guidance appears to point to decelerating growth. x.com
GitLab's revenue strength is not worth celebrating because it jammed sales and marketing spending to grab subscribers. x.com
GitLab is badly undervalued, with the market ignoring over $1B of ARR, $1.26B of cash and almost no debt at a $3.77B market cap and a $21–22 share price. A market-cap-over-DCF model gives a P50 value of $46.83 even before last night's AWS deal, with a path to $74.50 in 3–5 years. The biggest bear point is that nothing in Silicon Valley would be disrupted if GitLab stopped existing tomorrow because of AI. x.com x.com
GitLab is not worth investing in because of competition from Microsoft's GitHub, even after a 75% drawdown. AI won't replace the tool, and it has strong switching-cost and brand moats. x.com
Elevated AI risk makes GitLab a stock not worth being long at $60, despite a personal fair-value estimate at that level. A post by choblin29 reports that Anthropic replaced Git with its own version-control system and built Scion for code review. x.com x.com
GitLab looks mispriced against the data value implied by xAI's deal for an option to buy Cursor at $60 billion. At about $2.5 billion of enterprise value, GitLab's code data would be worth only around 5% of Cursor's, which is hard to believe; even a weak plan to monetize that data should spark a monster move, and if management won't, another company could acquire GitLab to exploit it. One caveat: a large share of GitLab is self-managed, so that portion cannot be trained on. x.com
GitLab faces an existential crisis as the AI "SaaSapocalypse" arrives, yet it still trades at 4.7x sales despite decelerating growth and 10+ analyst downgrades in 2026. x.com
GitLab is poorly placed to exploit GitHub's moment of weakness because its product is too similar to GitHub and in many ways worse. Hands-on testing found poor design: it took minutes to find where to create a repo, and pushing failed because force push to main was disabled. That explains why few are talking about migrating despite the stock's 50%+ fall over the past year. Unless it reinvents the product, it is not worth buying; whatever comes next in source control will look different. x.com … Show more
GitLab is buyable again with the worst of capitulation behind it, as platform usage rises. Its problem was a pricing model leading with full-platform sales at $20-30 a user, limiting upsell, but it is one of the few SaaS companies that can price for usage. DAP offers unpriced optionality for revenue acceleration or margin upside over time, and more in-house software development in sectors like healthcare and financials could support seats. A sale may still be the better outcome. x.com x.com
GitLab's restructuring plan earned it an analyst downgrade. x.com